Quest Diagnostics (DGX +4.3%) surges, thanks to a 1996 deal with Merck over osteoporosis drug...

|About: Quest Diagnostics Incorp... (DGX)|By:, SA News Editor

Quest Diagnostics (DGX +4.3%) surges, thanks to a 1996 deal with Merck over osteoporosis drug odanacatib, which may pay off to the tune of $75M. (earlier: success of odanacatib)